These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10125807)

  • 1. Fluconazole dosing in renal impairment: a drug usage evaluation.
    Moody SB; Sveska KJ
    Hosp Formul; 1993 May; 28(5):499-502. PubMed ID: 10125807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P&T Committee review of fluconazole: an effective alternative to antifungal therapy.
    Neu HC; Bennett JE; Bodey GP; Rubin RH; Schentag JJ; Sugar AM
    Hosp Formul; 1990 Mar; 25 Suppl B():9-14. PubMed ID: 10103976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and implementing guidelines to promote appropriate use of fluconazole therapy in an AIDS clinic.
    Anassi EO; Egbunike IG; Akpaffiong MJ; Ike EN; Cate TR
    Hosp Pharm; 1994 Jun; 29(6):576-8, 581-2, 585-6. PubMed ID: 10134178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside utilization study.
    Haslett TM; Reynolds JR
    Hosp Pharm; 1988 Oct; 23(10):872, 874-5, 878-80. PubMed ID: 10290108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate but not cost effective ceftazidime use in a university hospital.
    Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
    Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous metronidazole: a drug utilization review in a community hospital.
    Nessim D
    Can J Hosp Pharm; 1987 Feb; 40(1):6-11. PubMed ID: 10281259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic heparin monitoring service in a small community hospital.
    Pawloski SJ; Kersh PL
    Hosp Pharm; 1992 Aug; 27(8):703-6, 723. PubMed ID: 10119735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria-based antimicrobial i.v. to oral conversion program.
    Okpara AU; Maswoswe JJ; Stewart K
    Formulary; 1995 Jun; 30(6):343-8. PubMed ID: 10144873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the use of i.v. ciprofloxacin.
    Sesin GP; Stefanski L
    Hosp Formul; 1992 Oct; 27(10):1053-4. PubMed ID: 10121420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a drug usage evaluation program.
    Thornton J
    Hosp Formul; 1991 Dec; 26(12):971-2. PubMed ID: 10115411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A system for documentation of pharmacist interventions with incorporation into performance and quality improvement plans.
    Brown BL; Williamson SE
    Hosp Pharm; 1993 Nov; 28(11):1083-4, 1086-8. PubMed ID: 10130385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aminoglycoside monitoring service in a community hospital using a microcomputer.
    Voytovich RM; Outten RL
    Hosp Pharm; 1987 Mar; 22(3):267-72. PubMed ID: 10281372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist intervention program focused on i.v. ranitidine therapy.
    Santora J; Kitrenos JG; Green ER
    Am J Hosp Pharm; 1990 Jun; 47(6):1346-9. PubMed ID: 2368729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.